In vitro and in vivo activity of novel small-molecule inhibitors targeting the pleckstrin homology domain of protein kinase B/AKT.
暂无分享,去创建一个
Lei Du-Cuny | A. Skillman | Shuxing Zhang | G. Powis | Li Zhou | E. Meuillet | E. Mash | Shuxing Zhang | Robert Lemos | Garth Powis | Song Zuohe | Nathan Ihle | Li Li Zhou | Eugene A Mash | M Ahad Ali | Emmanuelle J Meuillet | Sylvestor A Moses | A Geoffrey Skillman | Robert Lemos | Lei Du-Cuny | N. Ihle | Sylvestor Moses | M. A. Ali | Song Zuohe
[1] P. Cohen,et al. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα , 1997, Current Biology.
[2] S. Goodman,et al. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. , 1993, The American journal of pathology.
[3] Andrius Kazlauskas,et al. PDGF- and insulin-dependent pp70S6k activation mediated by phosphatidylinositol-3-OH kinase , 1994, Nature.
[4] Jennifer Skeen,et al. Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. , 2003, Genes & development.
[5] G. Powis,et al. Specific inhibition of the Akt1 pleckstrin homology domain by D-3-deoxy-phosphatidyl-myo-inositol analogues. , 2003, Molecular cancer therapeutics.
[6] S. Wright,et al. NBD-TMA: a novel fluorescent substrate of the peritubular organic cation transporter of renal proximal tubules , 2000, Pflügers Archiv.
[7] J. Wesselink,et al. Molecular cloning, expression and characterization of the human serine/threonine kinase Akt-3. , 1999, European journal of biochemistry.
[8] Jesse D. Martinez,et al. Bile acid hydrophobicity is correlated with induction of apoptosis and/or growth arrest in HCT116 cells. , 2001, The Biochemical journal.
[9] Lei Du-Cuny,et al. Discovery of a novel class of AKT pleckstrin homology domain inhibitors , 2008, Molecular Cancer Therapeutics.
[10] Spyro Mousses,et al. A transforming mutation in the pleckstrin homology domain of AKT1 in cancer , 2007, Nature.
[11] S. Hewitt,et al. Spectrum of activity and molecular correlates of response to phosphatidylinositol ether lipid analogues, novel lipid-based inhibitors of Akt , 2006, Molecular Cancer Therapeutics.
[12] G. Paine-Murrieta,et al. Human tumor models in the severe combined immune deficient (scid) mouse , 1997, Cancer Chemotherapy and Pharmacology.
[13] G. Semenza,et al. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. , 2000, Cancer research.
[14] J. L. Bos,et al. ras oncogenes in human cancer: a review. , 1989, Cancer research.
[15] M. Hidalgo,et al. Exploiting novel molecular targets in gastrointestinal cancers. , 2007, World journal of gastroenterology.
[16] M. Montminy,et al. CREB Is a Regulatory Target for the Protein Kinase Akt/PKB* , 1998, The Journal of Biological Chemistry.
[17] Yiling Lu,et al. Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery , 2005, Nature Reviews Drug Discovery.
[18] N. C. Price,et al. Binding of phosphatidylinositol 3,4,5-trisphosphate to the pleckstrin homology domain of protein kinase B induces a conformational change. , 2003, The Biochemical journal.
[19] S. R. Datta,et al. Cellular survival: a play in three Akts. , 1999, Genes & development.
[20] I. Kuntz,et al. The maximal affinity of ligands. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[21] D R Alessi,et al. Phosphorylation of Ser-241 is essential for the activity of 3-phosphoinositide-dependent protein kinase-1: identification of five sites of phosphorylation in vivo. , 1999, The Biochemical journal.
[22] L. Cantley,et al. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[23] P. Workman,et al. Drugging the PI3 kinome , 2006, Nature Biotechnology.
[24] J. Woodgett,et al. Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. , 1998, The Biochemical journal.
[25] R. Weissleder,et al. Fate of a bioactive fluorescent wortmannin derivative in cells. , 2008, Bioconjugate chemistry.
[26] J. Woodgett,et al. Unravelling the activation mechanisms of protein kinase B/Akt , 2003, FEBS letters.
[27] W. Liu,et al. Up-regulation of Akt3 in Estrogen Receptor-deficient Breast Cancers and Androgen-independent Prostate Cancer Lines* , 1999, The Journal of Biological Chemistry.
[28] D. Guertin,et al. Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex , 2005, Science.
[29] G. Powis,et al. In vivo molecular pharmacology and antitumor activity of the targeted Akt inhibitor PX-316. , 2004, Oncology research.
[30] K. M. Nicholson,et al. The protein kinase B/Akt signalling pathway in human malignancy. , 2002, Cellular signalling.
[31] Nathan A. Baker,et al. PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations , 2004, Nucleic Acids Res..
[32] B. Burgering,et al. Essential Role for Protein Kinase B (PKB) in Insulin-induced Glycogen Synthase Kinase 3 Inactivation , 1998, The Journal of Biological Chemistry.
[33] C. E. Peishoff,et al. A critical assessment of docking programs and scoring functions. , 2006, Journal of medicinal chemistry.
[34] W. Wahli,et al. Dosage-Dependent Effects of Akt1/Protein Kinase Bα (PKBα) and Akt3/PKBγ on Thymus, Skin, and Cardiovascular and Nervous System Development in Mice , 2005, Molecular and Cellular Biology.
[35] Maria Deak,et al. High-Resolution Structure of the Pleckstrin Homology Domain of Protein Kinase B/Akt Bound to Phosphatidylinositol (3,4,5)-Trisphosphate , 2002, Current Biology.
[36] I. Campbell,et al. The phosphatidylinositol 3'-kinase p85alpha gene is an oncogene in human ovarian and colon tumors. , 2001, Cancer research.
[37] M. Rebecchi,et al. Pleckstrin homology domains: a common fold with diverse functions. , 1998, Annual review of biophysics and biomolecular structure.
[38] Qun Li. Recent progress in the discovery of Akt inhibitors as anticancer agents , 2007 .
[39] C. Roumestand,et al. Inhibition of Akt Kinase Activity by a Peptide Spanning the βA Strand of the Proto-oncogene TCL1* , 2004, Journal of Biological Chemistry.